Background This cross-sectional study aims to identify the relationship between perceived stress, social support and sleep quality and the effects of the COVID-19 pandemic on pregnant women's perceived stress, social support and sleep quality. Methods The target population of the study was pregnant women who applied to the Family Health Center. After the sample calculation was performed, the study involved 166 participants. The data, which were quantitative in nature, were collected through a web-based, online questionnaire administered within a determined period. Data collection tools included the Multidimensional Scale of Perceived Social Support (MSPSS), the Perceived Stress Scale (PSS), and the Pittsburgh Sleep Quality Index (PSQI). Results Of all the participating pregnant women, 88% reported to have poor sleep quality during the COVID-19 pandemic. A moderate, negative relationship was found between the Pittsburgh Sleep Quality Index and the Multidimensional Scale of Perceived Social Support and a weak, positive relationship with the Perceived Stress Scale. While statistically significant differences were found between the pregnant women's perceived stress according to their psychological perceptions and perceptions about daily life (P < 0.05), no significant differences were found between the perceived social support level and sleep quality index. Conclusion It was considered that pregnant women's perceived social support levels, sleep quality, and perceived stress levels were affected during the COVID-19 pandemic.
Purpose: This study investigates individuals' health perceptions and health anxiety within the framework of functional health patterns (FHP) during COVID-19 pandemic.Desing and Method: This study is a descriptive and cross-sectional design. Data were collected from participants (n = 3464) through a three-part web-based form.Findings: Individuals' health anxiety and perceptions are at a medium level. The participants' health perception and health anxiety scale mean scores demonstrated significant differences according to the FHP except for sexuality.Conclusions: It can be stated that individuals use the anxiety they experience to be vigilance against a potential health threat.Practice Implications: Researchers can use findings in the examination of psychological health problems that can be seen in individuals after the pandemic.
Geleneksel uygulamalara, sağlık alanında sıklıkla rastlanmaktadır. Özellikle doğum sonu dönemde lohusalara ve yenidoğanlara yönelik geleneksel uygulamalar, hastalık ve tehlikeleri önlemek amacıyla sıklıkla yapılmaktadır. Bu uygulamalar; âdetler, tören, dinsel ve büyüsel işlemlerden oluşmaktadır. Kültürümüzde lohusanın 40 gün süresince dinlenmesi, yalnız bırakılmaması oldukça önemlidir. Kadının beslenmesine, bakımına ve al basmasını önlemeye yönelik kültürel uygulamalar yapılmaktadır. Ayrıca, yenidoğanın beslenmesine, bakımına ilişkin uygulamalar ve bazı törensel uygulamalar da doğum sonu dönemde sıklıkla uygulanmaktadır.
This systematic review and meta-analysis study aims to determine the effects of the Covid-19 pandemic on the prevalence of insomnia, anxiety, and depression symptoms during pregnancy. Reviews were done through PubMed, EBSCO (Medline, CINAHL), Embase (OVID), Web of Science, PsycINFO, TR Index, Turkish Thesis Center databases using (pregnancy OR pregnant) and (sleep OR sleep disorders OR insomnia), and (anxiety OR depression) keywords between April and May 2021. The meta-analysis included 48 articles (sample: 77,299). It was found that the Covid-19 pandemic did not affect the prevalence of depression symptoms and anxiety during pregnancy, but it increased insomnia. While insomnia ratio was reported 39.6% (95% CI: 0.253–0.560) in the studies conducted before the pandemic, it was reported 88.8% (95% CI: 0.821–0.921) in the studies conducted during the pandemic. This study found that the Covid-19 pandemic did not have effects on depression symptoms and anxiety, but it increased insomnia complaints.
Aim: This study aims to determine the relationship between the late pregnancy and postpartum oxytocin levels and postpartum depression (PPD) symptoms. Methods: This longitudinal study was conducted with 70 pregnant women. Data collection was performed through two interviews. While the first interview was conducted in the 30th to 38th gestational weeks, the second interview was conducted in the 4th to 12th weeks in the postpartum period. Oxytocin level measurement was performed with a saliva sample. Saliva samples were analyzed with enzyme-linked immunosorbent assay kits. Results: The prevalence of depressive symptoms in the postpartum period was found significantly higher than the prevalence in late pregnancy. Depression symptoms reached the highest level in the 12th week. The late pregnancy oxytocin level was significantly higher than the postpartum oxytocin level. A weak, negative correlation was found between PPD symptoms and the late pregnancy oxytocin level. However, when linear regression analysis was performed, it was concluded that there was a medium, negative relationship model between PPD symptoms and the late pregnancy oxytocin level. However, no relationships were found between PPD symptoms and oxytocin level. Conclusion:In conclusion, this study found that the late pregnancy oxytocin level could be a predictive biomarker for postpartum depression. Predicting the risk of PPD in the pregnancy period could provide an opportunity for early diagnosis and treatment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.